Key Highlights
- CMS says the plan could save about $90 billion over 10 years.
- That equals about $9 billion per payment year.
- The proposal was released Monday, November 16.
- Comments are due January 19, 2027.
The headline number
The Centers for Medicare & Medicaid Services says its proposed rule to expand audits of Medicare Advantage plans could save about $90 billion over 10 years. CMS estimates the effect at about $9 billion per payment year, and the agency expects $90.2 billion to be recovered from 2027 through 2036.
The proposal, released Monday, November 16, is formally titled "Comprehensive Regulations to Uncover Suspicious Healthcare," or CRUSH. It is not final, and comments are due January 19, 2027.
Where the savings would come from
Medicare Advantage plans are private insurance plans that cover Medicare beneficiaries in place of the traditional government program. CMS pays the plans a set amount per member, adjusted upward for patients with more serious or costly health conditions. That adjustment depends on the diagnoses the plans report.
To check those reports, CMS runs risk adjustment data validation, or RADV, audits, reviewing a sample of medical records to see whether the diagnoses are supported. The CRUSH proposal would change the math in two ways, according to CMS's proposal as described in reports.
First, it would allow CMS to extrapolate audit findings from a sample of records to an entire contract. Rather than recovering money only for the specific errors found in the sample, CMS could apply the error rate across the whole plan, which can multiply the amount owed.
Second, it would extend the audit and overpayment lookback to payment year 2018, reaching further back into past payments.
Together, CMS says, those changes produce the projected savings. CMS Administrator Dr. Mehmet Oz framed the effort as a way to "crush fraud, waste, and abuse."
How Wall Street reads the estimate
One analyst said: "The substantially larger collection estimate reflects broader auditing." He added that CMS "could choose to make adjustments in the final rule." Oppenheimer expects legal challenges and thinks plans would price the cost into their bids.
The proposal revives a 2023 RADV rule that a federal judge in Texas vacated in September 2025 in a case brought by Humana (NYSE:HUM).
The market reaction
Insurer shares sold off for a second straight day on Wednesday. UnitedHealth Group (NYSE:UNH) tumbled and was the worst performer in the Dow Jones Industrial Average, while Humana plunged and was the worst performer in the S&P 500. Elevance Health (NYSE:ELV), Centene (NYSE:CNC) and CVS Health (NYSE:CVS) also sank.
Humana's exposure is especially large: Medicare Advantage accounted for $99.4 billion of its $129.7 billion in 2025 revenue.
The selling weighed on the broader market. The Dow fell 561.25 points to 50,198.17, with UnitedHealth the biggest drag. The S&P 500 slipped 16.90 points to 7,323.63, its fifth straight loss and its longest losing streak since June. Health care was among the weakest sectors, behind only energy.
What the Savings Estimate Means for Insurers
The comment period closing on January 19, 2027, is the next formal step, after which CMS can finalize, revise or delay the rule. Investors will watch whether the final version keeps the extrapolation method and the 2018 lookback, and whether the savings estimate changes. Any legal challenge to the rule, insurer commentary on the potential financial impact and UnitedHealth's 2027 outlook, which is due before year-end, will also be closely followed.






Please wait processing your request...